These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38072443)

  • 1. [Prospect of novel therapies in immune-mediated neuropathies].
    Kuwahara M
    Rinsho Shinkeigaku; 2024 Jan; 64(1):1-7. PubMed ID: 38072443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Immunoglobulin in the Treatment of Immune-Mediated Peripheral Neuropathies.
    Tobon A
    J Infus Nurs; 2017; 40(6):375-379. PubMed ID: 29112586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of immune neuropathies with intravenous immunoglobulins.
    Gold R; Kieseier BC
    J Neurol; 2006 Sep; 253 Suppl 5():V59-63. PubMed ID: 16998755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin Treatment in Neuromuscular Medicine.
    Burakgazi AZ
    J Clin Neuromuscul Dis; 2019 Jun; 20(4):182-193. PubMed ID: 31135621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in Peripheral Neuropathies.
    Léger JM; Guimarães-Costa R; Muntean C
    Neurotherapeutics; 2016 Jan; 13(1):96-107. PubMed ID: 26602549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
    Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on therapy of chronic immune-mediated neuropathies.
    Briani C; Cocito D; Campagnolo M; Doneddu PE; Nobile-Orazio E
    Neurol Sci; 2022 Dec; 43(Suppl 2):605-614. PubMed ID: 33452933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune mechanisms, the role of complement, and related therapies in autoimmune neuropathies.
    Latov N
    Expert Rev Clin Immunol; 2021 Dec; 17(12):1269-1281. PubMed ID: 34751638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.
    Franssen H; Straver DC
    Muscle Nerve; 2014 Jan; 49(1):4-20. PubMed ID: 24037667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
    Latov N
    Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated neuropathies.
    Kieseier BC; Mathey EK; Sommer C; Hartung HP
    Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of idiopathic inflammatory neuropathies.
    Donofrio PD
    Muscle Nerve; 2003 Sep; 28(3):273-92. PubMed ID: 12929187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of immune-mediated inflammatory neuropathies.
    Hadden RD; Hughes RA
    Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies.
    Dalakas MC
    Neurology; 2002 Dec; 59(12 Suppl 6):S13-21. PubMed ID: 12499466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fisher syndrome and Bickerstaff brainstem encephalitis].
    Kuwabara S
    Rinsho Shinkeigaku; 2014; 54(12):1056-7. PubMed ID: 25672708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.